309 related articles for article (PubMed ID: 33172776)
1. Adult parameningial alveolar rhabdomyosarcoma: Case report and literature review.
Barthère X; Guillerm S; Quero L; Le Maignan C; Torossian N; Verillaud B; Itti R; Hennequin C
Cancer Radiother; 2020 Dec; 24(8):870-875. PubMed ID: 33172776
[TBL] [Abstract][Full Text] [Related]
2. Management of alveolar rhabdomyosarcoma of the orbit.
Seregard S
Acta Ophthalmol Scand; 2002 Dec; 80(6):660-4. PubMed ID: 12485290
[No Abstract] [Full Text] [Related]
3. Intensity-modulated radiotherapy with use of cone-down boost for pediatric head-and-neck rhabdomyosarcoma.
McDonald MW; Esiashvili N; George BA; Katzenstein HM; Olson TA; Rapkin LB; Marcus RB
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):884-91. PubMed ID: 18455321
[TBL] [Abstract][Full Text] [Related]
4. Adult rhabdomyosarcoma in the nasal and paranasal sinuses showing complete local response to a combination of chemotherapy and radiotherapy using 3D-CRT and IMRT.
Muto E; Shioyama Y; Nakamura K; Ohga' S; Nomoto S; Toba T; Yoshitake T; Soeda H; Terashima H; Honda H
Fukuoka Igaku Zasshi; 2005 Oct; 96(10):363-9. PubMed ID: 16408493
[TBL] [Abstract][Full Text] [Related]
5. Volumetric considerations in radiotherapy for pediatric parameningeal rhabdomyosarcomas.
Chen C; Shu HK; Goldwein JW; Womer RB; Maity A
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1294-9. PubMed ID: 12654440
[TBL] [Abstract][Full Text] [Related]
6. Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults.
Dantonello TM; Int-Veen C; Harms D; Leuschner I; Schmidt BF; Herbst M; Juergens H; Scheel-Walter HG; Bielack SS; Klingebiel T; Dickerhoff R; Kirsch S; Brecht I; Schmelzle R; Greulich M; Gadner H; Greiner J; Marky I; Treuner J; Koscielniak E
J Clin Oncol; 2009 Mar; 27(9):1446-55. PubMed ID: 19224858
[TBL] [Abstract][Full Text] [Related]
7. [Alveolar rhabdomyosarcoma originating in spermatic cord: a case report].
Ozeki Z; Kobayashi S; Machida T; Kobayashi T; Oka K; Ishizaka K; Oka T
Hinyokika Kiyo; 2004 Sep; 50(9):653-5. PubMed ID: 15518135
[TBL] [Abstract][Full Text] [Related]
8. Rhabdomyosarcoma: the experience of the pediatric unit of Kasr El-Aini Center of Radiation Oncology and Nuclear Medicine (NEMROCK) (from January 1992 to January 2001).
Abd El-Aal HH; Habib EE; Mishrif MM
J Egypt Natl Canc Inst; 2006 Mar; 18(1):51-60. PubMed ID: 17237856
[TBL] [Abstract][Full Text] [Related]
9. Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric metastatic rhabdomyosarcoma when administered with irradiation and combination chemotherapy: a report from the Intergroup Rhabdomyosarcoma Study Group.
Breitfeld PP; Lyden E; Raney RB; Teot LA; Wharam M; Lobe T; Crist WM; Maurer HM; Donaldson SS; Ruymann FB
J Pediatr Hematol Oncol; 2001 May; 23(4):225-33. PubMed ID: 11846301
[TBL] [Abstract][Full Text] [Related]
10. Randomized comparison of intensified six-drug versus standard three-drug chemotherapy for high-risk nonmetastatic rhabdomyosarcoma and other chemotherapy-sensitive childhood soft tissue sarcomas: long-term results from the International Society of Pediatric Oncology MMT95 study.
Oberlin O; Rey A; Sanchez de Toledo J; Martelli H; Jenney ME; Scopinaro M; Bergeron C; Merks JH; Bouvet N; Ellershaw C; Kelsey A; Spooner D; Stevens MC
J Clin Oncol; 2012 Jul; 30(20):2457-65. PubMed ID: 22665534
[TBL] [Abstract][Full Text] [Related]
11. Cyclophosphamide dose escalation in combination with vincristine and actinomycin-D (VAC) in gross residual sarcoma. A pilot study without hematopoietic growth factor support evaluating toxicity and response.
Ruymann FB; Vietti T; Gehan E; Wiener E; Wharam M; Newton WA; Maurer H
J Pediatr Hematol Oncol; 1995 Nov; 17(4):331-7. PubMed ID: 7583389
[TBL] [Abstract][Full Text] [Related]
12. Rhabdomyosarcoma of the Gluteus Maximus - Case Report, Review of Literature and Emerging Therapeutic Targets.
Meshram GG; Kaur N; Hura SK
Klin Onkol; 2019; 32(3):201-207. PubMed ID: 31216853
[TBL] [Abstract][Full Text] [Related]
13. One-year survivor of adult alveolar rhabdomyosarcoma of the maxillary sinus with orbital extension: Case report.
Joo JH; Han JS; Choi SM; Park IK; Shin JH
Medicine (Baltimore); 2018 Aug; 97(35):e11866. PubMed ID: 30170378
[TBL] [Abstract][Full Text] [Related]
14. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group.
Meza JL; Anderson J; Pappo AS; Meyer WH;
J Clin Oncol; 2006 Aug; 24(24):3844-51. PubMed ID: 16921036
[TBL] [Abstract][Full Text] [Related]
15. Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease.
Crist WM; Anderson JR; Meza JL; Fryer C; Raney RB; Ruymann FB; Breneman J; Qualman SJ; Wiener E; Wharam M; Lobe T; Webber B; Maurer HM; Donaldson SS
J Clin Oncol; 2001 Jun; 19(12):3091-102. PubMed ID: 11408506
[TBL] [Abstract][Full Text] [Related]
16. Primary rhabdomyosarcoma of the breast in a 13-year-old girl: report of a case.
Nogi H; Kobayashi T; Kawase K; Tabei I; Toriumi Y; Suzuki M; Kawakami M; Morikawa T; Uchida K
Surg Today; 2007; 37(1):38-42. PubMed ID: 17186344
[TBL] [Abstract][Full Text] [Related]
17. Rhabdomyosarcoma in adults: analysis of treatment modalities in a prospective single-center series.
Bergamaschi L; Bertulli R; Casanova M; Provenzano S; Chiaravalli S; Gasparini P; Collini P; Sangalli C; Gandola L; Diletto B; Morosi C; Fiore M; Massimino M; Ferrari A
Med Oncol; 2019 May; 36(7):59. PubMed ID: 31104202
[TBL] [Abstract][Full Text] [Related]
18. Rhabdomyosarcoma of the orbit in a four months old infant in Zimbabwe: A case report.
Chitsike I; Masanganise R; Sibanda D; Kuona P
Cent Afr J Med; 2012; 58(5-6):26-9. PubMed ID: 26255332
[TBL] [Abstract][Full Text] [Related]
19. Asymptomatic expansile lesion in the nasolabial region of a 10-year-old child.
Libório TN; Capuano AC; Mantesso A; Gatti A; Nunes FD; Pinto-Junior DS
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Mar; 107(3):313-7. PubMed ID: 19071034
[No Abstract] [Full Text] [Related]
20. Treatment of intermediate risk rhabdomyosarcoma and undifferentiated sarcoma with alternating cycles of vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide.
Arndt CA; Nascimento AG; Schroeder G; Schomberg PJ; Neglia JP; Sencer SF; Silberman TL; Moertel CL; Tillisch JK; Miser JS
Eur J Cancer; 1998 Jul; 34(8):1224-9. PubMed ID: 9849484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
